ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | – | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | -60.0% |
| Q1 2019 | $1,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |